Please login to the form below

Not currently logged in
Email:
Password:

Pfizer tries to quash Trovan report in Nigeria

Pfizer initiates legal action in Nigerian Federal high court to quash a report by the Investigating Committee on Trovan

Pfizer has initiated a legal action in the Abuja division of the Nigerian Federal high court to quash a report by the Investigating Committee on the Trovan (trovafloxacin) clinical trial conducted in Kano state in 1996.

The government had charged Pfizer and eight others with alleged criminal application of trovafloxacin on 200 Nigerian children. The trial, it is alleged, killed many of the children and left others with various permanent disabilities.

The new Pfizer suit has demanded an order of certiorari (a type of writ seeking judicial review) and the action was assigned to Justice Anwuri Chikere for trial.

If successful, the certiorari could nullify the multiple criminal and civil actions against Pfizer Nigeria and individuals Isa Dutse, Scott Hopkins, Debra Williams, Mike Dunne, Samuel Ohuabunwa, Robert Buhl and William Steere, all of whom face a total 23-count charge.

The high court judge had granted Pfizer an extension of time to apply for leave to challenge the report. The accused could not be arraigned as they were not in court at the last adjourned date.

31st July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics